162 results on '"Caminero, Jose A."'
Search Results
2. Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
3. Treatment interruption patterns and adverse events among patients on bedaquiline containing regimen under programmatic conditions in India
4. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish society of pulmonology and thoracic surgery: 11 years on
5. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin
6. Update of SEPAR Guideline “Diagnosis and Treatment of Drug-Resistant Tuberculosis”
7. Evaluación del Programa Integrado de Investigación en Tuberculosis promovido por la sociedad española de Neumología y Cirugía Torácica tras 11 años de funcionamiento
8. Actualización de la normativa SEPAR «Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos»
9. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
10. Diagnosis and Treatment of Drug-Resistant Tuberculosis
11. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos
12. The challenge of the new tuberculosis drugs
13. Tuberculosis Costs in Spain and Related Factors
14. Costes de la tuberculosis en España: factores relacionados
15. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study
16. Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
17. A new plug-in for the creation of OPC servers based on EcosimPro© simulation software
18. Screening for Tuberculosis Infection in Spanish Healthcare Workers: Comparison of the QuantiFERON‐TB Gold In‐Tube Test with the Tuberculin Skin Test
19. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
20. Study of the Diagnostic Delay of Tuberculosis in Spain
21. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
22. Diagnosis and Treatment of Tuberculosis
23. Treatment of TB
24. Multidrug-resistant tuberculosis management in resource-limited settings
25. Management of Multidrug Resistant Tuberculosis
26. Chapter 10: Second-Line Antituberculosis Drugs: Current Knowledge, Recent Research Findings and Controversies
27. Influence of mannose-binding lectin on HIV infection and tuberculosis in a Western-European population
28. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
29. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis
30. Pulmonary/pleural tuberculosis
31. Treatment of drug-susceptible and drug-resistant tuberculosis
32. [Translated article] Drug Resistant Tuberculosis: New WHO Definitions and Their Implication in the SEPAR Guideline
33. Tuberculosis con resistencia a fármacos: nuevas definiciones de la OMS y su implicación en la Normativa de SEPAR
34. Comparison of bronchoscopic diagnostic techniques with histological findings in brain dead organ donors without suspected pneumonia
35. Estudio del retraso diagnóstico de la tuberculosis en España
36. Neutropenia secondary to tuberculosis treatment
37. Neutropenia secundaria al tratamiento de la tuberculosis
38. Tuberculosis in children. Challenges and opportunities
39. Tuberculosis en niños. Retos y oportunidades
40. The economic burden of multidrug-resistant tuberculosis
41. Management of Multidrug-Resistant Tuberculosis
42. ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
43. Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis
44. First Successful Use of Low Dose Amoxicillin-Clavulanic Acid in Management of Drug Resistant Tuberculosis
45. Bedaquiline: how better to use it
46. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
47. Bedaquiline and Delamanid: Salvage Therapy in Mycobacterium avium Infection With Treatment Failure
48. Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results
49. Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases
50. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.